Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment.
Caroline Kaercher KramerMatthew RetnakaranLuciana V VianaPublished in: The Journal of clinical endocrinology and metabolism (2024)
Our findings suggest that the use of liraglutide and semaglutide in patients who previously underwent MBS can promote significant weight reduction with an acceptable safety profile.